1. Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
2. CDC. Vital Signs: Prescription Painkiller Overdoses in the US. Morbidity and Mortality Weekly Reports. http://www.cdc.gov/vitalsigns/PainkillerOverdoses/index.html (accessed 29.09.14).
3. American Society of Addiction Medicine (ASAM). Advancing Access to Addiction Medications: Implications for Opioid Addiction Treatment. 2013.
4. Clinical pharmacology of buprenorphine: ceiling effects at high doses;Walsh;Clin. Pharmacol. Ther.,1994
5. Buprenorphine alone and in combination with naloxone in non-dependent humans;Weinhold;Drug Alcohol Depend.,1992